Stay updated with breaking news from Small Anim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canalevia-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID in dogs to receive any type of approval from the FDAVeterinary oncologists
Canalevia-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID in dogs to receive any type of approval from the FDAU.S. veterinarians, veterinary
Canalevia™-CA1, which received conditional approval from the FDAon December 21, 2021, is the first and only treatment for CID in dogs to receive any type of approval from the FDA ... | March 1, 2022
2021 was a year of progress for Jaguar Health as the company advanced its key human pipeline initiatives focused on chemotherapy-related diarrhea (CTD) and short bowel syndrome with intestinal failure
Canalevia-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID in dogs to receive any type of approval from FDAU.S. veterinarians, veterinary